ResearcherResearch Institute Hospital 12 de OctubreActive in the last 2 years
José Luis Rodríguez‐Peralto
Matched on ORCID iD 0000-0002-6578-7153; OpenAlex author ID A5086302273, A5120612530. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 5
- Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
- Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. Co-author DOI 10.1038/s41467-025-56894-8↗
- Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
- Acute sarcoidosis as a harbinger for pancreatic adenocarcinoma. Last author DOI 10.1016/j.pathol.2023.04.006↗
- Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR). Co-author DOI 10.3390/cancers14061518↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ana García García · 2 shared papers, 2022–2025 · strength 0.32
- Raúl Muñoz Velasco · 2 shared papers, 2022–2025 · strength 0.32
- Victor Javier Sanchez-Arevalo Lobo · 2 shared papers, 2022–2025 · strength 0.32
- Adriana Hogeboom · 1 shared paper, 2023 · strength 0.31
- Johannes V. Swinnen · 1 shared paper, 2025 · strength 0.18
- Bruno Sáinz · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.